Clinical trial
Investigation of Clofarabine in Acute Leukemias
NCT00098033 · University of Texas, Other · Completed
Key facts
| NCT number | NCT00098033 |
|---|---|
| Title | Investigation of Clofarabine in Acute Leukemias |
| Official title | Phase II Clinical and Pharmacodynamic Investigation of Clofarabine in Acute Leukemias |
| Lead sponsor | University of Texas, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia |
| Intervention type | Drug |
| Interventions | clofarabine |
| Enrollment | 64 |
| Start date | Sep 1, 2002 |
| Completion | Sep 1, 2005 |
| First posted | Dec 3, 2004 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: